Publications

PUBLICATIONS IN THE LAST FIVE YEARS FROM THE VANCOUVER STROKE PROGRAM:

Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk: Updated meta-analysis.

Charidimou A, Shoamanesh A, Wilson D, Gang Q, Fox Z, Jäger HR, Benavente OR, Werring DJ.

Neurology. 2015 Aug 21. pii: 10.1212/WNL.0000000000001923. [Epub ahead of print]

PMID: 26296519

 

Recurrent vascular events in lacunar stroke patients with metabolic syndrome and/or diabetes.

Zhu S, McClure LA, Lau H, Romero JR, White CL, Babikian V, Nguyen T, Benavente OR, Kase CS, Pikula A.

Neurology. 2015 Aug 21. pii: 10.1212/WNL.0000000000001933. [Epub ahead of print]

PMID: 26296518

 

CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study.

McDonough CW, McClure LA, Mitchell BD, Gong Y, Horenstein RB, Lewis JP, Field TS, Talbert RL, Benavente OR, Johnson JA, Shuldiner AR.

J Am Heart Assoc. 2015 May 27;4(6):e001652. doi: 10.1161/JAHA.114.001652.

PMID: 26019129

 

Cognitive performance following lacunar stroke in Spanish-speaking patients: results from the SPS3 trial.

Jacova C, Pearce LA, Roldan AM, Arauz A, Tapia J, Costello R, McClure LA, Hart RG, Benavente OR.

Int J Stroke. 2015 Jun;10(4):519-28. doi: 10.1111/ijs.12511.

PMID: 25973704

 

Can blood pressure be lowered safely in older adults with lacunar stroke? The Secondary Prevention of Small Subcortical Strokes study experience.

White CL, Szychowski JM, Pergola PE, Field TS, Talbert R, Lau H, Peri K, Benavente OR; Secondary Prevention of Small Subcortical Strokes Study Investigators.

J Am Geriatr Soc. 2015 Apr;63(4):722-9. doi: 10.1111/jgs.13349. Epub 2015 Apr 6.

PMID: 25850462

 

Left Ventricular Geometry on Transthoracic Echocardiogram and Prognosis after Lacunar Stroke: The SPS3 Trial.

Field TS, Pearce LA, Asinger RW, Smyth NG, De SK, Hart RG, Benavente OR; SPS3 Investigators.

J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1423-9. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.005. Epub 2015 Apr 1.

PMID: 25840952

 

Rapid Assessment and Treatment of Transient Ischemic Attacks and Minor Stroke in Canadian Emergency Departments: Time for a Paradigm Shift.

Kamal N, Hill MD, Blacquiere DP, Boulanger JM, Boyle K, Buck B, Butcher K, Camden MC, Casaubon LK, Côté R, Demchuk AM, Dowlatshahi D, Dubuc V, Field TS, Ghrooda E, Gioia L, Gladstone DJ, Goyal M, Gubitz GJ, Harris D, Hart RG, Hunter G, Jeerakathil T, Jin A, Khan K, Lang E, Lanthier S, Lindsay MP, Mackey A, Mandzia J, Mehdiratta M, Minuk J, Oczkowski W, Odier C, Penn A, Perry J, Pettersen JA, Phillips SJ, Poppe AY, Saposnik G, Selchen D, Shamy M, Sharma M, Shoamanesh A, Shuaib A, Silver F, Stotts G, Swartz R, Tamayo A, Teitelbaum J, Verreault S, Wein T, Yip S, Coutts SB.

Stroke. 2015 Oct;46(10):2987-90. doi: 10.1161/STROKEAHA.115.010454. Epub 2015 Aug 27. No abstract available.

PMID: 26316346

 

Vertebrobasilar ectasia in patients with lacunar stroke: the secondary prevention of small subcortical strokes trial.

Nakajima M, Pearce LA, Ohara N, Field TS, Bazan C, Anderson DC, Hart RG, Benavente OR; SPS3 Investigators.

J Stroke Cerebrovasc Dis. 2015 May;24(5):1052-8. doi: 10.1016/j.jstrokecerebrovasdis.2014.12.039. Epub 2015 Mar 25.

PMID: 25817614

 

Should Blood Pressure Targets After Lacunar Stroke Vary by Body Size? The SPS3 Trial.

Field TS, McClure LA, White CL, Pergola PE, Hart RG, Benavente OR, Hill MD; SPS3 Investigators.

Am J Hypertens. 2015 Jun;28(6):756-64. doi: 10.1093/ajh/hpu228. Epub 2014 Dec 1.

PMID: 25452300

 

Detection of occult atrial fibrillation in patients with embolic stroke of uncertain source: a work in progress.

Andrade JG, Field T, Khairy P.

Front Physiol. 2015 Apr 1;6:100. doi: 10.3389/fphys.2015.00100. eCollection 2015. Review.

PMID: 25883570

 

Post stroke pain: identification, assessment, and therapy.

Harrison RA, Field TS.

Cerebrovasc Dis. 2015;39(3-4):190-201. doi: 10.1159/000375397. Epub 2015 Mar 5.

PMID: 25766121

 

Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.

Coutts SB, Dubuc V, Mandzia J, Kenney C, Demchuk AM, Smith EE, Subramaniam S, Goyal M, Patil S, Menon BK, Barber PA, Dowlatshahi D, Field T, Asdaghi N, Camden MC, Hill MD; TEMPO-1 Investigators.

Stroke. 2015 Mar;46(3):769-74. doi: 10.1161/STROKEAHA.114.008504. Epub 2015 Feb 12.

PMID: 25677596

 

Early cerebral small vessel disease and brain volume, cognition, and gait.

Smith EE, O’Donnell M, Dagenais G, Lear SA, Wielgosz A, Sharma M, Poirier P, Stotts G, Black SE, Strother S, Noseworthy MD, Benavente O, Modi J, Goyal M, Batool S, Sanchez K, Hill V, McCreary CR, Frayne R, Islam S, DeJesus J, Rangarajan S, Teo K, Yusuf S; PURE Investigators.

Ann Neurol. 2015 Feb;77(2):251-61. doi: 10.1002/ana.24320.

PMID: 25428654

 

Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke: pooled analysis of randomized trials.

Kwok CS, Shoamanesh A, Copley HC, Myint PK, Loke YK, Benavente OR.

Stroke. 2015 Apr;46(4):1014-23. doi: 10.1161/STROKEAHA.114.008422. Epub 2015 Feb 26.

PMID: 25721018

 

Long-term disability after lacunar stroke: secondary prevention of small subcortical strokes.

Dhamoon MS, McClure LA, White CL, Lakshminarayan K, Benavente OR, Elkind MS; SPS3 Investigators.

Neurology. 2015 Mar 10;84(10):1002-8. doi: 10.1212/WNL.0000000000001331. Epub 2015 Feb 6.

PMID: 25663222

 

Prehospital use of magnesium sulfate as neuroprotection in acute stroke.

Saver JL, Starkman S, Eckstein M, Stratton SJ, Pratt FD, Hamilton S, Conwit R, Liebeskind DS, Sung G, Kramer I, Moreau G, Goldweber R, Sanossian N; FAST-MAG Investigators and Coordinators.

N Engl J Med. 2015 Feb 5;372(6):528-36. doi: 10.1056/NEJMoa1408827.

PMID: 25651247

 

Effect of addition of clopidogrel to aspirin on stroke incidence: Meta-analysis of randomized trials.

Palacio S, Hart RG, Pearce LA, Anderson DC, Sharma M, Birnbaum LA, Benavente OR.

Int J Stroke. 2015 Jul;10(5):686-91. doi: 10.1111/ijs.12050. Epub 2013 May 22.

PMID: 23692560

 

Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.

Pearce LA, McClure LA, Anderson DC, Jacova C, Sharma M, Hart RG, Benavente OR; SPS3 Investigators.

Lancet Neurol. 2014 Dec;13(12):1177-85. doi: 10.1016/S1474-4422(14)70224-8. Epub 2014 Oct 23.

PMID: 25453457

 

Clinical correlates of infarct shape and volume in lacunar strokes: the Secondary Prevention of Small Subcortical Strokes trial.

Asdaghi N, Pearce LA, Nakajima M, Field TS, Bazan C, Cermeno F, McClure LA, Anderson DC, Hart RG, Benavente OR; SPS3 Investigators.

Stroke. 2014 Oct;45(10):2952-8. doi: 10.1161/STROKEAHA.114.005211. Epub 2014 Sep 4.

PMID: 25190442

 

Predictors of mortality in patients with lacunar stroke in the secondary prevention of small subcortical strokes trial.

Sharma M, Pearce LA, Benavente OR, Anderson DC, Connolly SJ, Palacio S, Coffey CS, Hart RG.

Stroke. 2014 Oct;45(10):2989-94. doi: 10.1161/STROKEAHA.114.005789. Epub 2014 Aug 26.

PMID: 25158772

 

Lacunar strokes in patients with diabetes mellitus: risk factors, infarct location, and prognosis: the secondary prevention of small subcortical strokes study.

Palacio S, McClure LA, Benavente OR, Bazan C 3rd, Pergola P, Hart RG.

Stroke. 2014 Sep;45(9):2689-94. doi: 10.1161/STROKEAHA.114.005018. Epub 2014 Jul 17.

PMID: 25034716

 

The relevance of living supports on antiplatelet adherence and trial participation: the SPS3 trial.

Lewis BL, Pearce LA, Field TS, White CL, Benavente OR; SPS3 Investigators.

Int J Stroke. 2014 Jun;9(4):443-8. doi: 10.1111/ijs.12267. Epub 2014 Mar 24.

PMID: 24661819

 

Achieved blood pressures in the secondary prevention of small subcortical strokes (SPS3) study: challenges and lessons learned.

Pergola PE, White CL, Szychowski JM, Talbert R, Brutto OD, Castellanos M, Graves JW, Matamala G, Pretell EJ, Yee J, Rebello R, Zhang Y, Benavente OR; SPS3 Investigators.

Am J Hypertens. 2014 Aug;27(8):1052-60. doi: 10.1093/ajh/hpu027. Epub 2014 Mar 7.

PMID: 24610884

 

C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study.

Elkind MS, Luna JM, McClure LA, Zhang Y, Coffey CS, Roldan A, Del Brutto OH, Pretell EJ, Pettigrew LC, Meyer BC, Tapia J, White C, Benavente OR; LIMITS Investigators.

Stroke. 2014 Mar;45(3):707-16. doi: 10.1161/STROKEAHA.113.004562. Epub 2014 Feb 12.

PMID: 24523037

 

Quality of life after lacunar stroke: the Secondary Prevention of Small Subcortical Strokes study.

Dhamoon MS, McClure LA, White CL, Lau H, Benavente O, Elkind MS.

J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):1131-7. doi: 10.1016/j.jstrokecerebrovasdis.2013.09.029. Epub 2013 Oct 28.

PMID: 24177006

 

ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection?

Côté R, Zhang Y, Hart RG, McClure LA, Anderson DC, Talbert RL, Benavente OR.

Neurology. 2014 Feb 4;82(5):382-9. doi: 10.1212/WNL.0000000000000076. Epub 2014 Jan 2.

PMID: 24384643

 

Clinical-MRI correlations in a multiethnic cohort with recent lacunar stroke: the SPS3 trial.

Benavente OR, Pearce LA, Bazan C, Roldan AM, Catanese L, Bhat Livezey VM, Vidal-Pergola G, McClure LA, Hart RG; SPS3 Investigators.

Int J Stroke. 2014 Dec;9(8):1057-64. doi: 10.1111/ijs.12282. Epub 2014 May 27.

PMID: 24862645

 

Atrial fibrillation in patients with cryptogenic stroke.

Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O’Donnell M, Laupacis A, Côté R, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S, Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K, Aviv R, Kapral MK, Mamdani M; EMBRACE Investigators and Coordinators.

N Engl J Med. 2014 Jun 26;370(26):2467-77. doi: 10.1056/NEJMoa1311376.

PMID: 24963566

 

Good is not Good Enough: The Benchmark Stroke Door-to-Needle Time Should be 30 Minutes.

Kamal N, Benavente O, Boyle K, Buck B, Butcher K, Casaubon LK, Côté R, Demchuk AM, Deschaintre Y, Dowlatshahi D, Gubitz GJ, Hunter G, Jeerakathil T, Jin A, Lang E, Lanthier S, Lindsay P, Newcommon N, Mandzia J, Norris CM, Oczkowski W, Odier C, Phillips S, Poppe AY, Saposnik G, Selchen D, Shuaib A, Silver F, Smith EE, Stotts G, Suddes M, Swartz RH, Teal P, Watson T, Hill MD.

Can J Neurol Sci. 2014 Nov;41(6):694-6. doi: 10.1017/cjn.2014.41. Epub 2014 Oct 20. No abstract available.

PMID: 25376123

 

Bilateral internal carotid artery occlusion associated with the antiphospholipid antibody syndrome.

Anand P, Mann SK, Fischbein NJ, Lansberg MG.

Case Rep Neurol. 2014 Mar 5;6(1):50-4. doi: 10.1159/000360473. eCollection 2014 Jan.

PMID: 24707268

 

Spontaneous limb movements and posturing secondary to acute basilar artery occlusion: a potentially devastating seizure mimic.

Wilson LK, Benavente OR, Woolfenden AR, Asdaghi N.

Pract Neurol. 2014 Feb;14(1):42-4. doi: 10.1136/practneurol-2013-000585. Epub 2013 Sep 17.

PMID: 24046437

 

Aligning health care policy with evidence-based medicine: the case for funding direct oral anticoagulants in atrial fibrillation.

Stone JA, Earl KM, O’Neill BJ, Sharma M, Huynh T, Leblanc K, Ward R, Teal PA, Cox JL.

Can J Cardiol. 2014 Oct;30(10):1245-8. doi: 10.1016/j.cjca.2014.08.002.

PMID: 25262864

 

Larger A1/M1 diameter ratio predicts embolic anterior cerebral artery territorial stroke.

Shoamanesh A, Masoud H, Furey K, Duerfeldt K, Lau H, Romero JR, Pikula A, Teal P, Nguyen TN, Kase CS, Babikian VL.

Stroke. 2014 Sep;45(9):2798-800. doi: 10.1161/STROKEAHA.114.005672. Epub 2014 Jul 31.

PMID: 25082805

 

Status epilepticus amauroticus and posterior reversible encephalopathy syndrome in children.

Muro VL, Yip S, Huh L, Connolly MB.

J Clin Neurophysiol. 2013 Aug;30(4):344-7. doi: 10.1097/WNP.0b013e31829de004.

PMID: 23912571

 

Stem cell transplantation for adult-onset krabbe disease: report of a case.

Sharp ME, Laule C, Nantel S, Mädler B, Aul RB, Yip S, Sirrs S.

JIMD Rep. 2013;10:57-9. doi: 10.1007/8904_2012_203. Epub 2012 Dec 29.

PMID: 23430802

 

Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes.

Meschia JF, Arnett DK, Ay H, Brown RD Jr, Benavente OR, Cole JW, de Bakker PI, Dichgans M, Doheny KF, Fornage M, Grewal RP, Gwinn K, Jern C, Conde JJ, Johnson JA, Jood K, Laurie CC, Lee JM, Lindgren A, Markus HS, McArdle PF, McClure LA, Mitchell BD, Schmidt R, Rexrode KM, Rich SS, Rosand J, Rothwell PM, Rundek T, Sacco RL, Sharma P, Shuldiner AR, Slowik A, Wassertheil-Smoller S, Sudlow C, Thijs VN, Woo D, Worrall BB, Wu O, Kittner SJ; NINDS SiGN Study.

Stroke. 2013 Oct;44(10):2694-702. doi: 10.1161/STROKEAHA.113.001857. Epub 2013 Sep 10.

PMID: 24021684

 

Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortical strokes trial.

Hart RG, Pearce LA, Bakheet MF, Benavente OR, Conwit RA, McClure LA, Talbert RL, Anderson DC.

J Stroke Cerebrovasc Dis. 2014 Apr;23(4):618-24. doi: 10.1016/j.jstrokecerebrovasdis.2013.05.021. Epub 2013 Jun 22.

PMID: 23800503

 

Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial.

White CL, Pergola PE, Szychowski JM, Talbert R, Cervantes-Arriaga A, Clark HD, Del Brutto OH, Godoy IE, Hill MD, Pelegrí A, Sussman CR, Taylor AA, Valdivia J, Anderson DC, Conwit R, Benavente OR; SPS3 Investigators.

Am J Hypertens. 2013 Sep;26(9):1114-22. doi: 10.1093/ajh/hpt076. Epub 2013 Jun 4.

PMID: 23736109

 

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.

Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1).

Lancet Neurol. 2013 Aug;12(8):822-38. doi: 10.1016/S1474-4422(13)70124-8.

PMID: 23867200

 

A trial of imaging selection and endovascular treatment for ischemic stroke.

Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, Feng L, Meyer BC, Olson S, Schwamm LH, Yoo AJ, Marshall RS, Meyers PM, Yavagal DR, Wintermark M, Guzy J, Starkman S, Saver JL; MR RESCUE Investigators.

N Engl J Med. 2013 Mar 7;368(10):914-23. doi: 10.1056/NEJMoa1212793. Epub 2013 Feb 8.

PMID: 23394476

 

Combination aspirin and clopidogrel for secondary prevention of ischemic stroke.

Field TS, Nakajima M, Benavente OR.

Curr Treat Options Cardiovasc Med. 2013 Jun;15(3):348-59. doi: 10.1007/s11936-013-0241-x.

PMID: 23539482

 

A quantitative systematic review of domain-specific cognitive impairment in lacunar stroke.

Edwards JD, Jacova C, Sepehry AA, Pratt B, Benavente OR.

Neurology. 2013 Jan 15;80(3):315-22. doi: 10.1212/WNL.0b013e31827deb85. Review.

PMID: 23319476

 

 

Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.

Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators.

N Engl J Med. 2013 Mar 21;368(12):1092-100. doi: 10.1056/NEJMoa1301440.

PMID: 23514286

 

Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-analysis.

Shoamanesh A, Kwok CS, Lim PA, Benavente OR.

Int J Stroke. 2013 Jul;8(5):348-56. doi: 10.1111/j.1747-4949.2012.00869.x. Epub 2012 Sep 13. Review.

PMID: 22973896

 

Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.

SPS3 Investigators, Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA.

N Engl J Med. 2012 Aug 30;367(9):817-25. doi: 10.1056/NEJMoa1204133.

PMID: 22931315

 

Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials.

Palacio S, Hart RG, Pearce LA, Benavente OR.

Stroke. 2012 Aug;43(8):2157-62. doi: 10.1161/STROKEAHA.112.656173. Review.

PMID: 22826359

 

Prevention of deep vein thrombosis and pulmonary embolism in patients with stroke.

Field TS, Hill MD.

Clin Appl Thromb Hemost. 2012 Jan-Feb;18(1):5-19. doi: 10.1177/1076029611412362. Epub 2011 Jul 6. Review.

PMID: 21733942

 

Sample size re-estimation in an on-going NIH-sponsored clinical trial: the secondary prevention of small subcortical strokes experience.

McClure LA, Szychowski JM, Benavente O, Coffey CS.

Contemp Clin Trials. 2012 Sep;33(5):1088-93. doi: 10.1016/j.cct.2012.06.007. Epub 2012 Jun 30.

PMID: 22750086

 

Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial.

Lal BK, Beach KW, Roubin GS, Lutsep HL, Moore WS, Malas MB, Chiu D, Gonzales NR, Burke JL, Rinaldi M, Elmore JR, Weaver FA, Narins CR, Foster M, Hodgson KJ, Shepard AD, Meschia JF, Bergelin RO, Voeks JH, Howard G, Brott TG; CREST Investigators.

Lancet Neurol. 2012 Sep;11(9):755-63. Epub 2012 Aug 2.

PMID: 22857850

 

Cognitive impairment in lacunar strokes: the SPS3 trial.

Jacova C, Pearce LA, Costello R, McClure LA, Holliday SL, Hart RG, Benavente OR.

Ann Neurol. 2012 Sep;72(3):351-62. doi: 10.1002/ana.23733.

PMID: 23034910

 

Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial.

White CL, Szychowski JM, Roldan A, Benavente MF, Pretell EJ, Del Brutto OH, Kase CS, Arauz A, Meyer BC, Meissner I, Demaerschalk BM, McClure LA, Coffey CS, Pearce LA, Conwit R, Irby LH, Peri K, Pergola PE, Hart RG, Benavente OR; SPS3 Investigators.

J Stroke Cerebrovasc Dis. 2013 Aug;22(6):764-74. doi: 10.1016/j.jstrokecerebrovasdis.2012.03.002. Epub 2012 Apr 17.

PMID: 22516427

 

Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.

Turan TN, Lynn MJ, Nizam A, Lane B, Egan BM, Le NA, Lopes-Virella MF, Hermayer KL, Benavente O, White CL, Brown WV, Caskey MF, Steiner MR, Vilardo N, Stufflebean A, Derdeyn CP, Fiorella D, Janis S, Chimowitz MI; SAMMPRIS Investigators.

Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):e51-60. No abstract available.

PMID: 22991350

 

Predictors of lowering SBP to assigned targets at 12 months in the Secondary Prevention of Small Subcortical Strokes study.

Graves JW, White CL, Szychowski JM, Pergola PE, Benavente OR, Coffey CS, Hornung LN, Hart RG; SPS3 Study Investigators.

J Hypertens. 2012 Jun;30(6):1233-40. doi: 10.1097/HJH.0b013e328353968d.

PMID: 22499292

 

Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project.

Saver JL, Warach S, Janis S, Odenkirchen J, Becker K, Benavente O, Broderick J, Dromerick AW, Duncan P, Elkind MS, Johnston K, Kidwell CS, Meschia JF, Schwamm L; National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element Working Group.

Stroke. 2012 Apr;43(4):967-73. doi: 10.1161/STROKEAHA.111.634352. Epub 2012 Feb 2.

PMID: 22308239

 

The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines.

Bell AD, Roussin A, Cartier R, Chan WS, Douketis JD, Gupta A, Kraw ME, Lindsay TF, Love MP, Pannu N, Rabasa-Lhoret R, Shuaib A, Teal P, Théroux P, Turpie AG, Welsh RC, Tanguay JF; Canadian Cardiovascular Society.

Can J Cardiol. 2011 May-Jun;27 Suppl A:S1-59. doi: 10.1016/j.cjca.2010.12.015.

PMID: 21640290

 

Branch atheromatous disease: prognosis and management. The SPS3 experience.

Benavente O.

Rinsho Shinkeigaku. 2011 Nov;51(11):883. No abstract available.

PMID: 22277402

 

The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary.

Bell AD, Roussin A, Cartier R, Chan WS, Douketis JD, Gupta A, Kraw ME, Lindsay TF, Love MP, Pannu N, Rabasa-Lhoret R, Shuaib A, Teal P, Théroux P, Turpie AG, Welsh RC, Tanguay JF.

Can J Cardiol. 2011 Mar-Apr;27(2):208-21. doi: 10.1016/j.cjca.2010.12.033. Review. Erratum in: Can J Cardiol. 2011 Sep;27(5):663.

PMID: 21459270

 

Penetrating artery territory pontine infarction.

Field TS, Benavente OR.

Rev Neurol Dis. 2011;8(1-2):30-8. Review.

PMID: 21769069

 

Antiplatelet agents for stroke prevention.

Yip S, Benavente O.

Neurotherapeutics. 2011 Jul;8(3):475-87. doi: 10.1007/s13311-011-0060-2. Review.

PMID: 21761240

 

The correlates and course of depression in patients with lacunar stroke: results from the Secondary Prevention of Small Subcortical Strokes (SPS3) study.

White CL, McClure LA, Wallace PM, Braimah J, Liskay A, Roldan A, Benavente OR; SPS3 Investigators.

Cerebrovasc Dis. 2011;32(4):354-60. doi: 10.1159/000330350. Epub 2011 Sep 15.

PMID: 21921599

 

The Secondary Prevention of Small Subcortical Strokes (SPS3) study.

Benavente OR, White CL, Pearce L, Pergola P, Roldan A, Benavente MF, Coffey C, McClure LA, Szychowski JM, Conwit R, Heberling PA, Howard G, Bazan C, Vidal-Pergola G, Talbert R, Hart RG; SPS3 Investigators.

Int J Stroke. 2011 Apr;6(2):164-75. doi: 10.1111/j.1747-4949.2010.00573.x. Epub 2011 Jan 26.

PMID: 21371282

 

Changes in intracortical excitability after transient ischemic attack are associated with ABCD² score.

Edwards JD, Meehan SK, Levy AR, Teal PA, Linsdell MA, Boyd LA.

Stroke. 2011 Mar;42(3):728-33. doi: 10.1161/STROKEAHA.110.602938. Epub 2011 Jan 27.

PMID: 21273565

 

Current status of antiplatelet agents to prevent stroke.

Field TS, Benavente OR.

Curr Neurol Neurosci Rep. 2011 Feb;11(1):6-14. doi: 10.1007/s11910-010-0162-y. Review.

PMID: 21104164

 

Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

Amarenco P, Goldstein LB, Sillesen H, Benavente O, Zweifler RM, Callahan A 3rd, Hennerici MG, Zivin JA, Welch KM; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators.

Stroke. 2010 Mar;41(3):426-30. doi: 10.1161/STROKEAHA.109.564781. Epub 2010 Jan 28.

PMID: 20110538

 

Teaching NeuroImages: middle cerebral artery aneurysm rupture presenting as pure acute subdural hematoma.

Field TS, Heran MK.

Neurology. 2010 Jan 26;74(4):e13. doi: 10.1212/WNL.0b013e3181cc0b60. No abstract available.

PMID: 20101029

 

Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes.

Amarenco P, Benavente O, Goldstein LB, Callahan A 3rd, Sillesen H, Hennerici MG, Gilbert S, Rudolph AE, Simunovic L, Zivin JA, Welch KM; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators.

Stroke. 2009 Apr;40(4):1405-9. doi: 10.1161/STROKEAHA.108.534107. Epub 2009 Feb 19.

PMID: 19228842

 

Delayed detection of atrial fibrillation after ischemic stroke.

Kamel H, Lees KR, Lyden PD, Teal PA, Shuaib A, Ali M, Johnston SC; Virtual International Stroke Trials Archive Investigators.

J Stroke Cerebrovasc Dis. 2009 Nov-Dec;18(6):453-7. doi: 10.1016/j.jstrokecerebrovasdis.2009.01.012.

PMID: 19900647

 

A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT).

Teal P, Davis S, Hacke W, Kaste M, Lyden PD; Modified Randomized Exposure Controlled Trial Study Investigators, Fierus M; Bayer HealthCare AG.

Stroke. 2009 Nov;40(11):3518-25. doi: 10.1161/STROKEAHA.109.551382. Epub 2009 Sep 10.

PMID: 19745176